Author: Danielle Pillsbury
CERTAINTY – Japan
Location (City): Shinagawa, Tokyo Venue: TKP Garden City PREMIUM Shinagawa Takanawa GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to Certara experts, industry leaders and your peers with an opportunity hear the latest innovations and opportunities to achieve better certainty in drug development. Register now to be the first to know new details of … Continued
CERTAINTY – China
Location (City): in Shanghai Venue: Crowne Plaza Shanghai Jinxiu GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to Certara experts, industry leaders and your peers with an opportunity hear the latest innovations and opportunities to achieve better certainty in drug development. Register now to be the first to know new details of the event … Continued
CERTAINTY – South Korea
Location (City): in PangyoVenue: GRAVITY SEOUL PANGYO GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to Certara experts, industry leaders and your peers with an opportunity hear the latest innovations and opportunities to achieve better certainty in drug development. Register now to be the first to know new details of the event as we … Continued
RAPS Sponsored Webcast: 药物安全报告中的监管与技术进步
Meeting the escalating global demand for new medications requires expediting regulatory submission development. Documenting drug safety issues occurring in clinical research is a major aspect of regulatory and medical writing. Two major types of safety regulatory documents are the development safety update report (DSUR) and the patient safety narrative. This webcast will discuss the latest … Continued
药物开发人员需要经过整理的临床结果数据来为关键决策提供依据
在平行虚拟宇宙中开展临床试验
AI 赋能生物模拟：革新药物研发之路
地点Suzhou Adock Innovation Center (1F Multi-function Lecture Hall, Adock Innovation Center, No. 328 Xinghu Street, Suzhou Industrial Park, Suzhou, China) Overview: 随着科技的飞速发展，AI 技术已经深入到我们生活的方方面面。In the field of drug research and development, the combination of AI and biosimulation has brought revolutionary changes … Continued
神经平台：建立阿尔茨海默病的 QSP 综合机制模型，为药物发现和开发提供支持
With over 55 million people diagnosed worldwide, Alzheimer’s disease presents a significant public health challenge, with treatment costs and caregiver burden reaching staggering figures, expected to exceed a trillion dollars soon. Explore the latest insights into Alzheimer’s disease and drug development in Dr. Hugo Geerts’ presentation at the University of Indiana. Learn about the development … Continued
用 Simcyp™ 探索内源性生物标记物的世界！
Endogenous biomarkers play a pivotal role in comprehending drug-body interactions, shaping drug development, and propelling precision medicine forward. With our latest software release, the Simcyp™ Simulator introduces innovative features tailored to endogenous biomarkers. In a comprehensive overview led by our expert presenter, Dr. Matthew Harwood, Principal Scientist in Translational DMPK, shares insights into: Dr. Harwood … Continued
